<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity.	</title>
	<atom:link href="https://gennova.bio/experience-with-generic-pegylated-l-asparaginase-in-children-with-acute-lymphoblastic-leukemia-and-monitoring-of-serum-asparaginase-activity/feed/" rel="self" type="application/rss+xml" />
	<link>https://gennova.bio/experience-with-generic-pegylated-l-asparaginase-in-children-with-acute-lymphoblastic-leukemia-and-monitoring-of-serum-asparaginase-activity/</link>
	<description>Transforming Healthcare</description>
	<lastBuildDate>Tue, 14 Apr 2020 15:00:26 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>
</channel>
</rss>
